Font Size: a A A
Keyword [after Percutaneous Coronary Intervention]
Result: 141 - 160 | Page: 8 of 10
141. The Relationship Between Heme Oxygenase-1 Gene Polymorphisms And Non-culprit Lesions After Percutaneous Coronary Intervention In Coronary Heart Disease Patients
142. A Clinical Study On Shenkang Injection Combined With High Does Atorvasatin To Preventing Contrast-induced Nephropathy After Percutaneous Coronary Intervention
143. The Clinical Reasrch Of Yang Xin Jie Yu Soup To Treat Mild Depression Disorder In The Elderly After Percutaneous Coronary Intervention
144. Quantitative Assessment Of Mitral Apparatus In Patients With Acute Myocardial Infarction After Percutaneous Coronary Intervention By Real-time Three-dimensional Transthoracic Echocardiography
145. Analysis Of In-stent Restenosis Related Factors After Percutaneous Coronary Intervention
146. Risk Factor Analysis For Contrast-induced Nephropathy In Patients Of Acute Coronary Syndrome With Normal Or Slightly Impaired Renal Function After Percutaneous Coronary Intervention
147. Effects Of Danlou Tablet On The Periprocedural Myocardial Injury Of ACS Patient After Percutaneous Coronary Intervention
148. Assessment Of Left Ventricular Function In Patients With Acute Myocardial Infarction Before And After Percutaneous Coronary Intervention By Four-dimensional Strain Technique
149. The Predictive Value Of Red Cell Distribution Width For The Long-term Prognosis Of Patients With Acute ST Elevation Myocardial Infarction After Percutaneous Coronary Intervention
150. A Study Of Quality Of Life For Patients With CHD Before And After Percutaneous Coronary Intervention And The Influence Factors Of Quality Of Life
151. Study On The TCM Syndrome Of Patients After Percutaneous Coronary Intervention In Kunming District
152. Research On The Relation Of Restenosis After Percutaneous Coronary Intervention And The Pathogenesis Of Qi Deficiency To Blood Stasis
153. Effect Of Nursing Intervention On Self-Management Level And Quality Of Life Of Patients After Percutaneous Coronary Intervention
154. Effect Of Vitamin E For Preventing The Contrast Induced Acute Kidney Injury In Patients With Coronary Artery Disease After Percutaneous Coronary Intervention
155. Selection Of Anti-platelet Drug In Patients With Acute Coronary Syndrome(ACS) After Percutaneous Coronary Intervention Guided By CYP2C19
156. Effects Of Angiotensin Converting Enzyme Inhibitor On Contrast-Induced Nephropathy After Percutaneous Coronary Intervention
157. Prediction Value By The Ratio Of Contrast Media And Estimated Glomerular Filtration Rate For Contrast-Induced Nephropathy After Percutaneous Coronary Intervention
158. Application Of Intravascular Ultrasound Combined With C Reactive Protein And Micro RNAs In The Monitoring Of Late Incomplete Stent Apposition In Patients After Percutaneous Coronary Intervention
159. The Study On The Effects And Mechanisms Of Angiotensin ? Type 1 Receptor Autoantibody-mediated Apoptosis Of Endothelial Progenitor Cells In Patients Of In-stent Restenosis After Percutaneous Coronary Intervention
160. The Influence Of The PRECEDE-PROCEED Model On Medication Adherence After Percutaneous Coronary Intervention
  <<First  <Prev  Next>  Last>>  Jump to